OIG Report Highlights FDA Cybersecurity Problems, Recommends Fixes
This article was originally published in The Gray Sheet
Executive Summary
The oversight agency identified several vulnerabilities on FDA’s web site and databases after a cybersecurity breach last year allowed hackers to access data on thousands of FDA clients and raised concern with congressional leaders. FDA says it has fixed the identified issues.
You may also be interested in...
FDA Cybersecurity Again In Spotlight As Hackers Breach CBER’s Database
A hacker gained access to information from about 14,000 users of the Center for Biologics Evaluation and Research’s submission systems during the government shutdown.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.